You need to enable JavaScript to run this app.
FDA questions on genAI-enabled chatbots raise concerns from expert panel
Regulatory News
Jeff Craven
Advisory committees
Artificial intelligence/machine learning (AI/ML)
CDRH
Digital health/SaMD/AI
Medical De... See more
Long-term exposure to high levels of the industrial degreasing chemical trichloroethylene (TCE) was associated with an increased risk for Parkinson’s disease (PD), a new study showed.
Using data from the US Environmental Protection Agency (EPA) National A... See more
Over the past decade, more adults in the US report experiencing problems with concentration, memory, and decision-making.
While adults of all ages reported these issues, researchers found that the rate of cognitive disability nearly doubled among those yo... See more
The novel serotonin norepinephrine reuptake inhibitor (SNRI) ammoxetine may effectively treat major depressive disorder (MDD) while avoiding some side effects common to other antidepressants, new phase 2 data suggested.
Investigators found that participan... See more
